{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T15:34:20Z","timestamp":1781710460560,"version":"3.54.5"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation","doi-asserted-by":"publisher","award":["81630093"],"award-info":[{"award-number":["81630093"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation","doi-asserted-by":"publisher","award":["81402804"],"award-info":[{"award-number":["81402804"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation","doi-asserted-by":"publisher","award":["81273383"],"award-info":[{"award-number":["81273383"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.taap.2017.03.004","type":"journal-article","created":{"date-parts":[[2017,3,9]],"date-time":"2017-03-09T14:47:06Z","timestamp":1489070826000},"page":"104-112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Biatriosporin D displays anti-virulence activity through decreasing the intracellular cAMP levels"],"prefix":"10.1016","volume":"322","author":[{"given":"Ming","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqiang","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongzhuo","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxiang","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2017.03.004_bb0005","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1091\/mbc.E06-10-0931","article-title":"Identification of an N-Acetylglucosamine transporter that mediates hyphal induction in Candida albicans","volume":"18","author":"Alvarez","year":"2007","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.taap.2017.03.004_bb0010","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1039\/C3NP70058E","article-title":"Industrial natural product chemistry for drug discovery and development","volume":"31","author":"Bauer","year":"2014","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.taap.2017.03.004_bb0015","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1128\/MMBR.00009-06","article-title":"Environmental sensing and signal transduction pathways regulating morphopathogenic determinants of Candida albicans","volume":"71","author":"Biswas","year":"2007","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.taap.2017.03.004_bb0020","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.mib.2013.03.007","article-title":"Candida albicans biofilms: building a heterogeneous, drug-tolerant environment","volume":"16","author":"Bonhomme","year":"2013","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.taap.2017.03.004_bb0025","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.bbagen.2011.02.001","article-title":"Retigeric acid B exerts antifungal effect through enhanced reactive oxygen species and decreased cAMP","volume":"1810","author":"Chang","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.taap.2017.03.004_bb0030","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1248\/bpb.b12-00511","article-title":"Retigeric acid B enhances the efficacy of azoles combating the virulence and biofilm formation of Candida albicans","volume":"35","author":"Chang","year":"2012","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.taap.2017.03.004_bb0035","article-title":"Retigeric acid B attenuates the virulence of Candida albicans via inhibiting adenylyl cyclase activity targeted by enhanced farnesol production","volume":"7","author":"Chang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.taap.2017.03.004_bb0040","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1091\/mbc.12.11.3631","article-title":"Signaling through adenylyl cyclase is essential for hyphal growth and virulence in the pathogenic fungus Candida albicans","volume":"12","author":"Cintia","year":"2001","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.taap.2017.03.004_bb0045","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.tim.2010.02.004","article-title":"Therapy for fungal diseases: opportunities and priorities","volume":"18","author":"Denning","year":"2010","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.taap.2017.03.004_bb0050","doi-asserted-by":"crossref","first-page":"30895","DOI":"10.1039\/C5RA26092B","article-title":"HSAF-induced antifungal effects in Candida albicans through ROS-mediated apoptosis","volume":"6","author":"Ding","year":"2016","journal-title":"RSC Adv."},{"key":"10.1016\/j.taap.2017.03.004_bb0055","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1128\/CMR.15.2.167-193.2002","article-title":"Biofilms: survival mechanisms of clinically relevant microorganisms","volume":"15","author":"Donlan","year":"2002","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.taap.2017.03.004_bb0060","article-title":"Virulence factors of Candida albicans","volume":"9","author":"Fonzi","year":"2001","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.taap.2017.03.004_bb0065","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.mib.2011.06.001","article-title":"Mucosal biofilms of Candida albicans","volume":"14","author":"Ganguly","year":"2011","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.taap.2017.03.004_bb0070","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.drudis.2008.11.013","article-title":"Targeting virulence: a new paradigm for antifungals","volume":"14","author":"Gauwerky","year":"2009","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.taap.2017.03.004_bb0075","series-title":"Attributable Mortality of Nosocomial Candidemia, Revisited","first-page":"1172","volume":"37","author":"Gudlaugsson","year":"2003"},{"key":"10.1016\/j.taap.2017.03.004_bb0080","doi-asserted-by":"crossref","first-page":"23575","DOI":"10.1038\/srep23575","article-title":"Inhibitory effect of sophorolipid on Candida albicans biofilm formation and hyphal growth","volume":"6","author":"Haque","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.taap.2017.03.004_bb0085","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.micinf.2009.04.018","article-title":"Biofilm formation in clinical Candida isolates and its association with virulence","volume":"11","author":"Hasan","year":"2009","journal-title":"Microbes Infect."},{"key":"10.1016\/j.taap.2017.03.004_bb0090","series-title":"Virulence in Candida Species","author":"Haynes","year":"2001"},{"key":"10.1016\/j.taap.2017.03.004_bb0095","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.2217\/fmb.09.106","article-title":"The Ras\/cAMP\/PKA signaling pathway and virulence in Candida albicans","volume":"4","author":"Hogan","year":"2009","journal-title":"Future Microbiol"},{"key":"10.1016\/j.taap.2017.03.004_bb0100","doi-asserted-by":"crossref","first-page":"251","DOI":"10.4161\/viru.20010","article-title":"Regulation of phenotypic transitions in the fungal pathogen Candida albicans","volume":"3","author":"Huang","year":"2012","journal-title":"Virulence"},{"key":"10.1016\/j.taap.2017.03.004_bb0105","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1016\/j.mycmed.2014.11.002","article-title":"Dermatomycoses and inflammation: the adaptive balance between growth, damage, and survival","volume":"25","author":"Hube","year":"2015","journal-title":"J. Mycologie Medicale"},{"key":"10.1016\/j.taap.2017.03.004_bb0110","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1586\/eri.11.152","article-title":"Candida albicans dimorphism as a therapeutic target","volume":"10","author":"Jacobsen","year":"2012","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"10.1016\/j.taap.2017.03.004_bb0115","article-title":"Small molecule inhibitors of the Candida albicans budded-to-hyphal transition act through multiple signaling pathways","volume":"6","author":"John Midkiff","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.taap.2017.03.004_bb0120","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1099\/mic.0.26517-0","article-title":"The cAMP phosphodiesterase encoded by CaPDE2 is required for hyphal development in Candida albicans","volume":"149","author":"Jung","year":"2003","journal-title":"Microbiology"},{"key":"10.1016\/j.taap.2017.03.004_bb0125","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.2217\/fmb.09.98","article-title":"Cellular interactions of farnesol, a quorum-sensing molecule produced by Candida albicans","volume":"4","author":"Langford","year":"2009","journal-title":"Future Microbiol"},{"key":"10.1016\/j.taap.2017.03.004_bb0130","article-title":"Diorcinol D exerts fungicidal action against Candida albicans through cytoplasm membrane destruction and ROS accumulation","volume":"10","author":"Li","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.taap.2017.03.004_bb0135","doi-asserted-by":"crossref","DOI":"10.1093\/femsyr\/fov060","article-title":"Natural product solasodine-3-O-beta-d-glucopyranoside inhibits the virulence factors of Candida albicans","volume":"15","author":"Li","year":"2015","journal-title":"FEMS Yeast Res."},{"key":"10.1016\/j.taap.2017.03.004_bb0140","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.taap.2016.09.014","article-title":"Riccardin D-N induces lysosomal membrane permeabilization by inhibiting acid sphingomyelinase and interfering with sphingomyelin metabolism in vivo","volume":"310","author":"Li","year":"2016","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2017.03.004_bb0145","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1128\/EC.00144-12","article-title":"Farnesol and cyclic AMP signaling effects on the hypha-to-yeast transition in Candida albicans","volume":"11","author":"Lindsay","year":"2012","journal-title":"Eukaryot. Cell"},{"key":"10.1016\/j.taap.2017.03.004_bb0150","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/S1369-5274(01)00275-2","article-title":"Transcriptional control of dimorphism in Candida albicans","volume":"4","author":"Liu","year":"2001","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.taap.2017.03.004_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.micres.2015.05.007","article-title":"Mutations in the Flo8 transcription factor contribute to virulence and phenotypic traits in Candida albicans strains","volume":"178","author":"Liu","year":"2015","journal-title":"Microbiol. Res."},{"key":"10.1016\/j.taap.2017.03.004_bb0165","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0092-8674(00)80358-X","article-title":"Nonfilamentous C. albicans mutants are avirulent","volume":"90","author":"Lo","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.taap.2017.03.004_bb0170","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4161\/viru.22913","article-title":"Candida albicans pathogenicity mechanisms","volume":"4","author":"Mayer","year":"2013","journal-title":"Virulence"},{"key":"10.1016\/j.taap.2017.03.004_bb0175","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nature17625","article-title":"Candidalysin is a fungal peptide toxin critical for mucosal infection","volume":"532","author":"Moyes","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.taap.2017.03.004_bb0180","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.mib.2006.06.007","article-title":"Candida albicans biofilm development, modeling a host-pathogen interaction","volume":"9","author":"Nett","year":"2006","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.taap.2017.03.004_bb0185","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1021\/np200906s","article-title":"Natural products as sources of new drugs over the 30years from 1981 to 2010","volume":"75","author":"Newman","year":"2012","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.taap.2017.03.004_bb0190","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1128\/CMR.00029-06","article-title":"Epidemiology of invasive candidiasis: a persistent public health problem","volume":"20","author":"Pfaller","year":"2007","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.taap.2017.03.004_bb0195","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1086\/516315","article-title":"Oropharyngeal and esophageal candidiasis in immunocompromised patients: treatment issues","volume":"26","author":"Rabih","year":"1998","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.taap.2017.03.004_bb0200","doi-asserted-by":"crossref","first-page":"5459","DOI":"10.1128\/AEM.68.11.5459-5463.2002","article-title":"Inhibition of Candida albicans biofilm formation by farnesol, a quorum-sensing molecule","volume":"68","author":"Ramage","year":"2002","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.taap.2017.03.004_bb0205","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1128\/EC.4.4.633-638.2005","article-title":"Candida biofilms: an update","volume":"4","author":"Ramage","year":"2005","journal-title":"Eukaryot. Cell"},{"key":"10.1016\/j.taap.2017.03.004_bb0210","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/j.1567-1364.2006.00117.x","article-title":"Candida biofilms on implanted biomaterials: a clinically significant problem","volume":"6","author":"Ramage","year":"2006","journal-title":"FEMS Yeast Res."},{"key":"10.1016\/j.taap.2017.03.004_bb0215","series-title":"Maintenance of C. elegans. WormBook: The Online Review of C. elegans Biology","first-page":"1","author":"Stiernagle","year":"2006"},{"key":"10.1016\/j.taap.2017.03.004_bb0220","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/nrmicro2636","article-title":"Growth of Candida albicans hyphae","volume":"9","author":"Sudbery","year":"2011","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.taap.2017.03.004_bb0225","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.tim.2004.05.008","article-title":"The distinct morphogenic states of Candida albicans","volume":"12","author":"Sudbery","year":"2004","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.taap.2017.03.004_bb0230","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/jam.12737","article-title":"Synergistic activity of magnolol with azoles and its possible antifungal mechanism against Candida albicans","volume":"118","author":"Sun","year":"2015","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/j.taap.2017.03.004_bb0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028953","article-title":"Bisbibenzyls, a new type of antifungal agent, inhibit morphogenesis switch and biofilm formation through upregulation of DPP3 in Candida albicans","volume":"6","author":"Zhang","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.taap.2017.03.004_bb0240","article-title":"Effect of tetrandrine against Candida albicans biofilms","volume":"8","author":"Zhao","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.taap.2017.03.004_bb0245","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jnatprod.5b00998","article-title":"Heptaketides from an endolichenic fungus Biatriospora sp. and their antifungal activity","author":"Zhou","year":"2016","journal-title":"J. Nat. Prod."}],"updated-by":[{"DOI":"10.1016\/j.taap.2021.115828","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2022,1,15]],"date-time":"2022-01-15T00:00:00Z","timestamp":1642204800000}}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X17301023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X17301023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T13:56:02Z","timestamp":1535982962000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X17301023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":48,"alternative-id":["S0041008X17301023"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2017.03.004","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.taap.2021.115828","asserted-by":"object"}]},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biatriosporin D displays anti-virulence activity through decreasing the intracellular cAMP levels","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2017.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}